24 November 2024

Howe Street Reporter Title

Tag: Lexaria Bioscience

  • Stocks to Watch: Lexaria Bioscience (LEXX.Q) sees gains

    Stocks to Watch: Lexaria Bioscience (LEXX.Q) sees gains

    Special Delivery Lexaria Bioscience Corp. (LEXX.Q) is a biotechnology company developing DehydraTECH™, the Company’s proprietary drug delivery technology. In addition to enhancing the speed and efficiency of orally-delivered drugs, DehydraTECH has demonstrated effectiveness in improving delivery through human skin for the potential development of topically-administered products such as patches. Through various animal studies evaluating the quantity…

  • Lexaria (LXX.C) recieves a…R&D license?

    Lexaria (LXX.C) recieves a…R&D license?

    Earlier this week, a subsidiary of Lexaria Bioscience (LXX.C) received a R&D license from Health Canada, prompting the question, ‘we have those?’ “You were as surprised as we were,” said Alex Blanchard, communications manager for Lexaria. Lexaria isn’t your average grower. The company is much more of a tech-play, developing new delivery systems for nicotine, vitamins,…